Business Description
Tempest Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US87978U1088
Description
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.25 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 1.55 | |||||
| Debt-to-EBITDA | -0.53 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 14.2 | |||||
| 3-Year EPS without NRI Growth Rate | 12.9 | |||||
| 3-Year FCF Growth Rate | 14.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.82 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.54 | |||||
| 9-Day RSI | 26.39 | |||||
| 14-Day RSI | 31.96 | |||||
| 3-1 Month Momentum % | -33.34 | |||||
| 6-1 Month Momentum % | -68.1 | |||||
| 12-1 Month Momentum % | -75.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.69 | |||||
| Quick Ratio | 1.69 | |||||
| Cash Ratio | 1.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.2 | |||||
| Shareholder Yield % | -112.5 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -238.04 | |||||
| ROA % | -90.62 | |||||
| ROIC % | -187.2 | |||||
| 3-Year ROIIC % | -73.05 | |||||
| ROC (Joel Greenblatt) % | -324.27 | |||||
| ROCE % | -121.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.94 | |||||
| Price-to-Tangible-Book | 1.86 | |||||
| EV-to-EBIT | -0.94 | |||||
| EV-to-Forward-EBIT | -0.71 | |||||
| EV-to-EBITDA | -0.95 | |||||
| EV-to-Forward-EBITDA | -0.71 | |||||
| EV-to-FCF | -1.09 | |||||
| Price-to-Net-Current-Asset-Value | 20 | |||||
| Earnings Yield (Greenblatt) % | -106.38 | |||||
| FCF Yield % | -80.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TPST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tempest Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.53 | ||
| Beta | -2.94 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 4.01 | ||
| Volatility % | 63.23 | ||
| 14-Day RSI | 31.96 | ||
| 14-Day ATR ($) | 0.076557 | ||
| 20-Day SMA ($) | 0.89169 | ||
| 12-1 Month Momentum % | -75.77 | ||
| 52-Week Range ($) | 0.79 - 6 | ||
| Shares Outstanding (Mil) | 43.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tempest Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tempest Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tempest Therapeutics Inc Frequently Asked Questions
What is Tempest Therapeutics Inc(TPST)'s stock price today?
The current price of TPST is $0.80. The 52 week high of TPST is $6.00 and 52 week low is $0.79.
When is next earnings date of Tempest Therapeutics Inc(TPST)?
The next earnings date of Tempest Therapeutics Inc(TPST) is 2025-03-19 Est..
Does Tempest Therapeutics Inc(TPST) pay dividends? If so, how much?
Tempest Therapeutics Inc(TPST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers